Feature Channels: Biotech

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 6-Nov-2024 8:00 AM EST Released to reporters: 1-Nov-2024 8:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Nov-2024 8:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: A Newly Developed Algorithm Shows How a Gene Is Expressed at Microscopic Resolution
Released: 31-Oct-2024 1:50 PM EDT
A Newly Developed Algorithm Shows How a Gene Is Expressed at Microscopic Resolution
Michigan Medicine - University of Michigan

A new method developed by University of Michigan researchers creates images that are worth many gigabytes of data, which could revolutionize the way biologists study gene expression.

Released: 31-Oct-2024 12:20 PM EDT
Pioneering Scientist David Deamer to receive ABRF Award for Outstanding Contributions to Biomolecular Technologies
Association of Biomolecular Resource Facilities (ABRF)

The Association of Biomolecular Resource Facilities (ABRF) is pleased to announce the selection of David Deamer, Ph.D., Research Professor of Biomolecular Engineering at the University of California, Santa Cruz as the next recipient of the ABRF Award, which recognizes Outstanding Contributions to Biomolecular Technologies. Over his scientific career, Deamer has focused on biological and synthetic membranes. In 1989, Deamer proposed that it may be possible to sequence a DNA molecule by passing it through a nanoscopic pore embedded in a lipid bilayer membrane.

Released: 31-Oct-2024 8:10 AM EDT
SynCardia Granted Second Patent Covering Fully Implantable Artificial Heart
SynCardia Systems, LLC

SynCardia Systems, LLC., a Picard Medical Inc. company, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a second patent (US patent no. 12,121,711 B2) that will expand the coverage of SynCardia's fully implantable artificial heart technology (SynCardia Emperor). The USPTO allowed the first patent (US patent no. 11,918,797) relating to its groundbreaking "Next Generation Total Artificial Heart" designs in March of this year.

Newswise: Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey
Released: 30-Oct-2024 3:40 PM EDT
Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey
Rutgers University-New Brunswick

New Jersey Gov. Phil Murphy joined Rutgers and community leaders on Oct. 30 at the Child Health Institute in New Brunswick to celebrate a $47.5 million federal grant for the Rutgers Institute for Translational Medicine and Science that will improve health and well-being for New Jersey residents over the next seven years.

Released: 30-Oct-2024 12:15 PM EDT
Discovery Illuminates How Sleeping Sickness Parasite Outsmarts Immune Response
Johns Hopkins Bloomberg School of Public Health

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health sheds light on how the blood-borne parasite that causes African sleeping sickness in humans and related diseases in cattle and other animals establishes long-term infections in hosts. Using a mouse model, the researchers showed thatTrypanosoma brucei essentially plays a game of hide-and-seek by setting up shop in its hosts’ tissues, allowing it to constantly change its protective surface coat and evade antibodies.

Released: 30-Oct-2024 12:00 PM EDT
Enhancing the Functionality of Mesenchymal Stem Cells: An Attractive Treatment Strategy for Metabolic Dysfunction-Associated Steatotic Liver Disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Newswise:Video Embedded complexity-of-tumors-revealed-in-3d
VIDEO
28-Oct-2024 2:25 PM EDT
Complexity of Tumors Revealed in 3D
Washington University in St. Louis

A new analysis led by researchers at Washington University School of Medicine in St. Louis has revealed detailed 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal how different tumor cells — and the cells of a tumor’s surrounding environment — are organized, in 3D, and how that organization changes when a tumor spreads to other organs. The detailed findings offer scientists valuable blueprints of tumors that could lead to new approaches to therapy and spark a new era in the field of cancer biology, according to the researchers.

Newswise: Study Identifies How Ovarian Cancer Protects Itself, Paves Way for Improved Immunotherapy Approach
25-Oct-2024 1:05 PM EDT
Study Identifies How Ovarian Cancer Protects Itself, Paves Way for Improved Immunotherapy Approach
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study, published in the October 30 online issue of Cell used a cutting-edge spatial genomics technology and preclinical animal models, with tumor specimens from ovarian cancer patients further validating the findings. They found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which is typically associated with asthma and the skin condition eczema, also known as atopic dermatitis. The study went on to find that the cancer cells used IL-4 to create a protective environment that kept away killer immune cells, making the tumors resistant to immunotherapy. A drug, dupilumab, which blocks IL-4’s activity, has been approved by the Food and Drug Administration (FDA) and is already used to treat asthma and eczema. This new study suggests dupi

Newswise: Breakthrough in Taro Research: New Gene Silencing System Enables Rapid Gene Function Verification
Released: 30-Oct-2024 10:40 AM EDT
Breakthrough in Taro Research: New Gene Silencing System Enables Rapid Gene Function Verification
Chinese Academy of Sciences

A research team has established a Virus-Induced Gene Silencing (VIGS) system in taro, enabling researchers to rapidly verify gene functions in this underutilized crop.

Released: 28-Oct-2024 12:00 PM EDT
Enhancing the Functionality of Mesenchymal Stem Cells: An Attractive Treatment Strategy for Metabolic Dysfunction-Associated Steatotic Liver Disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Newswise: Encrypted Peptides, New Class of Antibiotics, Offer Hope in Fight Against Antibiotic Resistance
21-Oct-2024 4:30 PM EDT
Encrypted Peptides, New Class of Antibiotics, Offer Hope in Fight Against Antibiotic Resistance
Perelman School of Medicine at the University of Pennsylvania

In a significant advance against the growing threat of antibiotic-resistant bacteria, , researchers have identified a novel class of antimicrobial agents known as encrypted peptides, which may expand the immune system’s arsenal of tools to fight infection.

Newswise: Danforth Technology Company Launches New Startup
Released: 28-Oct-2024 9:30 AM EDT
Danforth Technology Company Launches New Startup
Donald Danforth Plant Science Center

The Danforth Technology Company (DTC) today announced the launch of Metablify, a startup that has developed a breakthrough technology platform that enables the detection and quantification of previously undetectable metabolites and chemicals in large numbers of biological samples processed using LC/MS data processing algorithms.

Released: 26-Oct-2024 12:00 PM EDT
Gamma-aminobutyric acid enhances miR-21-5p loading into adipose-derived stem cell extracellular vesicles to alleviate myocardial ischemia-reperfusion injury via TXNIP regulation
World Journal of Stem Cells

BACKGROUNDMyocardial ischemia-reperfusion injury (MIRI) poses a prevalent challenge in current reperfusion therapies, with an absence of efficacious interventions to address the underlying causes. AIMTo investigate whether the extracellula

Released: 26-Oct-2024 12:00 PM EDT
Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Released: 26-Oct-2024 12:00 PM EDT
Emergence of the stromal vascular fraction and secretome in regenerative medicine
World Journal of Stem Cells

Recently, we read a mini-review published by Jeyaraman et al. The article explored the optimal methods for isolating mesenchymal stromal cells from adipose tissue-derived stromal vascular fraction (SVF). Key factors include tissue source, p

Released: 26-Oct-2024 12:00 PM EDT
Enhancing the Functionality of Mesenchymal Stem Cells: An Attractive Treatment Strategy for Metabolic Dysfunction-Associated Steatotic Liver Disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Released: 26-Oct-2024 12:00 PM EDT
Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Released: 26-Oct-2024 12:00 PM EDT
Enhancing the Functionality of Mesenchymal Stem Cells: An Attractive Treatment Strategy for Metabolic Dysfunction-Associated Steatotic Liver Disease?
World Journal of Stem Cells

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema

Released: 26-Oct-2024 12:00 PM EDT
Bioengineering breakthroughs: The impact of stem cell models on advanced therapy medicinal product development
World Journal of Stem Cells

The burgeoning field of bioengineering has witnessed significant strides due to the advent of stem cell models, particularly in their application in advanced therapy medicinal products (ATMPs). In this review, we examine the multifaceted im



close
2.77423